Market Place
Sourcing Support
Theramex Announces Agreement to Acquire the European Rights to Duphaston
10 Oct 2023 //
BUSINESSWIRE
Theramex Enters Into Agreement With Radius Health to Commercialise ELADYNOS
20 Mar 2023 //
BUSINESSWIRE
Scottish Medicines Consortium accepts Theramex’ Bijuve HRT on NHS Scotland
13 Sep 2022 //
PHARMAPHORUM
Theramex Announces EC Marketing Authorization for Yselty in Uterine Fibroids
17 Jun 2022 //
BUSINESSWIRE
Theramex Launches Non-hormonal Femarelle® on the 12th of May
09 May 2022 //
BUSINESSWIRE
Theramex Supports the IOF SCOPE 2021 Recommendations and Call to Action
21 Mar 2022 //
BUSINESSWIRE
Theramex Australia Enters Partnership With Endoceutics For Intrarosa
14 Feb 2022 //
BUSINESSWIRE
Theramex, ObsEva Sign Licensing Agreement for Linzagolix in Uterine Fibroids
10 Feb 2022 //
BUSINESSWIRE
Theramex, Enzene Partner for the Development & Commercialisation of Tocilizumab
23 Dec 2021 //
BUSINESSWIRE
Theramex, Enzene Partner for the Development & Commercialisation of Tocilizumab
23 Dec 2021 //
BUSINESSWIRE
Theramex launches Femarelle to treat menopause symptoms
16 Nov 2021 //
PHARMAFILE
Theramex Enters OTC Market with Femarelle
15 Nov 2021 //
BUSINESSWIRE
Safety results from real-world study in comb. oral contraception published
14 Oct 2021 //
BUSINESSWIRE
PRAC starts reviewing risk of tumors linked to women’s health products
07 Oct 2021 //
RAPS
Theramex pioneers new treatment for post-menopausal women
24 Sep 2021 //
PHARMAFILE
Theramex launches Bijuva (estradiol and progesterone)
21 Sep 2021 //
BUSINESSWIRE
Theramex Appoints Sigurd Kirk to the Board of Directors
12 Jul 2021 //
BUSINESSWIRE
Theramex announces license agreement for Prolia biosimilar in EU and Australia
14 Jun 2021 //
GOODWIN
Theramex UK announces a license and supply agreement with Enzene Biosciences
10 Jun 2021 //
PHARMIWEB
Theramex launches Livogiva®, teriparatide pre-filled pen severe osteoporosis
19 Jan 2021 //
PHARMIWEB
Theramex launches osteoporosis drug Livogiva in Europe
18 Jan 2021 //
PHARMAFILE
Theramex Acquires Commercial Rights for Oral Contraceptive Zoely
23 Jan 2020 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.